RecruitingNot ApplicableNCT06539026

Inferior Vena Cava Collapsibility Index Guide for Preoperative Fluid Therapy in Preeclampsia

Ultrasound Assessment of Inferior Vena Cava Collapsibility Index (IVCCI) to Guide Pre-operative Fluid Management in Critically Ill Pre-eclamptic Patients in Comparison with the Standard Fluid Management


Sponsor

Ain Shams University

Enrollment

90 participants

Start Date

Aug 15, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The routine assessment of fluid status depends on clinical evaluation and invasive monitoring. The clinical assessment lacks objectivity and the invasive monitoring carries risks. Point of care ultrasound (POCUS) parameters can be useful as early markers of fluid status and were used in safe fluid assessment in term pregnancy and preeclampsia.


Eligibility

Sex: FEMALE

Plain Language Summary

Simplified for easier understanding

This trial is studying a way to guide how much IV fluid to give before cesarean section in pregnant patients with preeclampsia (a serious condition involving high blood pressure in pregnancy). It uses an ultrasound measurement of a large blood vessel in the abdomen (the inferior vena cava) to estimate whether the patient needs more or less fluid, with the goal of reducing dangerous blood pressure drops during surgery. **You may be eligible if...** - You are critically ill with preeclampsia and are scheduled for a cesarean section **You may NOT be eligible if...** - You refuse to participate - You have severe heart disease (low ejection fraction) or a leaky heart valve (tricuspid regurgitation) - You cannot safely receive spinal anesthesia - You have severe liver or kidney problems Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERfluid therapy, 300 ml of crystalloid Ringer's solution.

300 ml by dripping within 30 minutes, the fluid will be repeated by half the amount if needed to reach equal or less than 50% collapsibility. the fluid that will be used is sterile Ringer's solution which is an isotonic intravenous solution with pH 5.0 - 7.5 and an osmolality of 308mOsmol/kg.


Locations(1)

Ain shams university

Cairo, Egypt, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06539026


Related Trials